Delivery Order SPE2DB22D9367-SPE2DB24FSW03

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $14,486.24 order is for BEYFORTUS 100 MG/ML SYRINGEML with a completion date of February 2, 2024. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract with DLA valued up to $4,999,999 through 2025 to provide a broad range of pharmaceutical items to military health facilities....
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The $18,107.70 contract is for the delivery of BEYFORTUS 100 MG/ML SYRINGEML and has a completion date of February 2, 2024. This contract is not set-aside. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, with the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide BEYFORTUS 100 MG/ML SYRINGEML. The contract has no set-aside designation, is valued at $22,420.45, and has a completion date of February 28, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a wide range of brand and generic prescription and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,573.50, is for the delivery of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,711.25 delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order and is not associated with a set-aside designation. DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $18,107.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through February 2, 2024, is for the supply of the pharmaceutical product BEYFORTUS 100 MG/ML SYRINGEML. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a significant indefinite delivery contract (IDC) with the DLA under the...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $9,053.85 order is for BEYFORTUS 100 MG/ML SYRINGEML and is part of a larger, single-award indefinite delivery contract valued up to $4,999,999 through 2025. The contract enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $15,032.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the procurement of BEYFORTUS 100 MG/ML SYRINGEML, with a completion date of September 30, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, valued at $5,432.31, is for the delivery of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 2, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that has previously held indefinite delivery contracts with DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical distributor based in Park Ridge, Illinois. The $90,538.50 firm fixed-price contract is for the delivery of BEYFORTUS 100 mg/mL syringes. The award has no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued up to $4,999,999 through 2025. This...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSW03
    Delivery Order

This is a $18,107.70 delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of BEYFORTUS 100 MG/ML SYRINGE/ML, with a completion date of February 2, 2024. The contract does not have a set-aside designation.

DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic prescription and over-the-counter drug supplies worldwide. The firm holds a larger indefinite delivery contract with the DLA, valued at up to $4,999,999 through the end of 2025, which enables the agency to issue firm fixed-price delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities supported by DLA globally.

Generated 5/2/24, 11:00 AM